302. IMPACT OF ERAS BENCHMARK ACHIEVEMENTS AND HYBRID ROBOTIC ASSISTED ESOPHAGECTOMY ON RECOVERY AND READMISSION IN AN ERAS CENTER OVER TIME

Abstract Background Early recovery after surgery (ERAS) guidelines have provided an effective recovery approach for esophagectomy. Adherence to ERAS benchmarks leads to improvements in accelerated recovery over time. We evaluated differences in ERAS clinical benchmark achievements in patients underg...

Full description

Saved in:
Bibliographic Details
Published in:Diseases of the esophagus 2023-08, Vol.36 (Supplement_2)
Main Authors: Stiles, Erik, Harrison, Madison, Qaraqe, Taha, Sternbach, Joel, Low, Donald, Hubka, Michal
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue Supplement_2
container_start_page
container_title Diseases of the esophagus
container_volume 36
creator Stiles, Erik
Harrison, Madison
Qaraqe, Taha
Sternbach, Joel
Low, Donald
Hubka, Michal
description Abstract Background Early recovery after surgery (ERAS) guidelines have provided an effective recovery approach for esophagectomy. Adherence to ERAS benchmarks leads to improvements in accelerated recovery over time. We evaluated differences in ERAS clinical benchmark achievements in patients undergoing hybrid robotic assisted esophagectomy (hRAMIE) and the impact on length of hospital stay (LOS). We also examined the overall performance of our ERAS program and impact of operative technique on recovery and readmissions over time. Methods A single-center prospective database of esophageal cancer patients was retrospectively analyzed between January 2020 and December 2022. All consecutive patients underwent hRAMIE within a standardized ERAS pathway. Impact of individual ERAS benchmark achievements on postoperative outcomes were evaluated according to LOS groups: accelerated (≤6 days, AR), targeted (7–8 days, TR), and delayed recovery (≥9 days, DR). Ability to achieve AR and readmission rates were compared with previous esophagectomy patient cohorts and institutional published data. Data were tested for normality with Shapiro–Wilk testing. Continuous variables were compared via ANOVA or Kruskal-Wallis testing. Categorical variables were compared via Fisher testing. Results Sixty-four patients underwent hRAMIE with a median LOS 5.5 days. AR, TR, and DR was achieved by 75.0%, 18.8%, and 6.3% patients, respectively. AR outperformed the other groups in ICU stay (p = 0.0046), transition to PO medications (p 
doi_str_mv 10.1093/dote/doad052.128
format article
fullrecord <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_dote_doad052_128</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/dote/doad052.128</oup_id><sourcerecordid>10.1093/dote/doad052.128</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1198-db3880ae096bcbb280cbf96c9e699505de2809cd29ce3270593f5992914853bc3</originalsourceid><addsrcrecordid>eNqFkD9PwzAQxS0EEqWwM3pHKWc7Se3RddzGookrJ1TqFOWvBAIVNTDwHfjQuLQ7y93p7r130g-hewIzAoI9dvvP3pe6g4jOCOUXaELCkAYUIrj0M6EQ8FiE1-hmHF8ByJzFfIJ-GNAZNtlGqhLbJdZOFnihc5Vm0j1hqVKjtzrTeVlgmSc43S2cSbCzC1sahWVRmKLUCdaF3aRypVVpsx22OXZa2a12uz-X0zLJjNf6g8n96vRH-Vjt8FGHS5PpW3Q11G9jf3fuU_S81KVKg7VdGSXXQUuI4EHXMM6h7kHETds0lEPbDCJuRR8LEUHU9X4l2o6Ktmd0DpFgQyQEFSTkEWtaNkVwym0P-3E89EP1cXh5rw_fFYHqSLM60qzONCtP01seTpb918f_6l_peGxw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>302. IMPACT OF ERAS BENCHMARK ACHIEVEMENTS AND HYBRID ROBOTIC ASSISTED ESOPHAGECTOMY ON RECOVERY AND READMISSION IN AN ERAS CENTER OVER TIME</title><source>Oxford Journals Online</source><creator>Stiles, Erik ; Harrison, Madison ; Qaraqe, Taha ; Sternbach, Joel ; Low, Donald ; Hubka, Michal</creator><creatorcontrib>Stiles, Erik ; Harrison, Madison ; Qaraqe, Taha ; Sternbach, Joel ; Low, Donald ; Hubka, Michal</creatorcontrib><description>Abstract Background Early recovery after surgery (ERAS) guidelines have provided an effective recovery approach for esophagectomy. Adherence to ERAS benchmarks leads to improvements in accelerated recovery over time. We evaluated differences in ERAS clinical benchmark achievements in patients undergoing hybrid robotic assisted esophagectomy (hRAMIE) and the impact on length of hospital stay (LOS). We also examined the overall performance of our ERAS program and impact of operative technique on recovery and readmissions over time. Methods A single-center prospective database of esophageal cancer patients was retrospectively analyzed between January 2020 and December 2022. All consecutive patients underwent hRAMIE within a standardized ERAS pathway. Impact of individual ERAS benchmark achievements on postoperative outcomes were evaluated according to LOS groups: accelerated (≤6 days, AR), targeted (7–8 days, TR), and delayed recovery (≥9 days, DR). Ability to achieve AR and readmission rates were compared with previous esophagectomy patient cohorts and institutional published data. Data were tested for normality with Shapiro–Wilk testing. Continuous variables were compared via ANOVA or Kruskal-Wallis testing. Categorical variables were compared via Fisher testing. Results Sixty-four patients underwent hRAMIE with a median LOS 5.5 days. AR, TR, and DR was achieved by 75.0%, 18.8%, and 6.3% patients, respectively. AR outperformed the other groups in ICU stay (p = 0.0046), transition to PO medications (p &lt; 0.0001), and chest tube removal (p = 0.0002). Complications (48.4%) were more frequent among the TR and DR groups (p = 0.0051). 30-day readmission rate of 9.4% did not differ among the recovery groups (AR 6.2%, TR 25.0%, DR 0%, p = 0.114). 90-day mortality was 4.7% and disproportionately impacted the DR group (p = 0.0203). AR increased overtime without impacting readmission rate compared to previous cohorts in our ERAS center (Figure 1). Conclusion Within a common ERAS pathway at a single center, adherence to recovery benchmarks in patients undergoing hRAMIE multiplies the impact of ERAS and evolving operative technique on accelerated recovery across time. Improvements in AR can be achieved without affecting readmission rates. Routine audit of achievements of ERAS benchmarks is necessary to maintain post-esophagectomy outcomes in a time of changing health care resources.</description><identifier>ISSN: 1120-8694</identifier><identifier>EISSN: 1442-2050</identifier><identifier>DOI: 10.1093/dote/doad052.128</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>Diseases of the esophagus, 2023-08, Vol.36 (Supplement_2)</ispartof><rights>The Author(s) 2023. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Stiles, Erik</creatorcontrib><creatorcontrib>Harrison, Madison</creatorcontrib><creatorcontrib>Qaraqe, Taha</creatorcontrib><creatorcontrib>Sternbach, Joel</creatorcontrib><creatorcontrib>Low, Donald</creatorcontrib><creatorcontrib>Hubka, Michal</creatorcontrib><title>302. IMPACT OF ERAS BENCHMARK ACHIEVEMENTS AND HYBRID ROBOTIC ASSISTED ESOPHAGECTOMY ON RECOVERY AND READMISSION IN AN ERAS CENTER OVER TIME</title><title>Diseases of the esophagus</title><description>Abstract Background Early recovery after surgery (ERAS) guidelines have provided an effective recovery approach for esophagectomy. Adherence to ERAS benchmarks leads to improvements in accelerated recovery over time. We evaluated differences in ERAS clinical benchmark achievements in patients undergoing hybrid robotic assisted esophagectomy (hRAMIE) and the impact on length of hospital stay (LOS). We also examined the overall performance of our ERAS program and impact of operative technique on recovery and readmissions over time. Methods A single-center prospective database of esophageal cancer patients was retrospectively analyzed between January 2020 and December 2022. All consecutive patients underwent hRAMIE within a standardized ERAS pathway. Impact of individual ERAS benchmark achievements on postoperative outcomes were evaluated according to LOS groups: accelerated (≤6 days, AR), targeted (7–8 days, TR), and delayed recovery (≥9 days, DR). Ability to achieve AR and readmission rates were compared with previous esophagectomy patient cohorts and institutional published data. Data were tested for normality with Shapiro–Wilk testing. Continuous variables were compared via ANOVA or Kruskal-Wallis testing. Categorical variables were compared via Fisher testing. Results Sixty-four patients underwent hRAMIE with a median LOS 5.5 days. AR, TR, and DR was achieved by 75.0%, 18.8%, and 6.3% patients, respectively. AR outperformed the other groups in ICU stay (p = 0.0046), transition to PO medications (p &lt; 0.0001), and chest tube removal (p = 0.0002). Complications (48.4%) were more frequent among the TR and DR groups (p = 0.0051). 30-day readmission rate of 9.4% did not differ among the recovery groups (AR 6.2%, TR 25.0%, DR 0%, p = 0.114). 90-day mortality was 4.7% and disproportionately impacted the DR group (p = 0.0203). AR increased overtime without impacting readmission rate compared to previous cohorts in our ERAS center (Figure 1). Conclusion Within a common ERAS pathway at a single center, adherence to recovery benchmarks in patients undergoing hRAMIE multiplies the impact of ERAS and evolving operative technique on accelerated recovery across time. Improvements in AR can be achieved without affecting readmission rates. Routine audit of achievements of ERAS benchmarks is necessary to maintain post-esophagectomy outcomes in a time of changing health care resources.</description><issn>1120-8694</issn><issn>1442-2050</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFkD9PwzAQxS0EEqWwM3pHKWc7Se3RddzGookrJ1TqFOWvBAIVNTDwHfjQuLQ7y93p7r130g-hewIzAoI9dvvP3pe6g4jOCOUXaELCkAYUIrj0M6EQ8FiE1-hmHF8ByJzFfIJ-GNAZNtlGqhLbJdZOFnihc5Vm0j1hqVKjtzrTeVlgmSc43S2cSbCzC1sahWVRmKLUCdaF3aRypVVpsx22OXZa2a12uz-X0zLJjNf6g8n96vRH-Vjt8FGHS5PpW3Q11G9jf3fuU_S81KVKg7VdGSXXQUuI4EHXMM6h7kHETds0lEPbDCJuRR8LEUHU9X4l2o6Ktmd0DpFgQyQEFSTkEWtaNkVwym0P-3E89EP1cXh5rw_fFYHqSLM60qzONCtP01seTpb918f_6l_peGxw</recordid><startdate>20230830</startdate><enddate>20230830</enddate><creator>Stiles, Erik</creator><creator>Harrison, Madison</creator><creator>Qaraqe, Taha</creator><creator>Sternbach, Joel</creator><creator>Low, Donald</creator><creator>Hubka, Michal</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20230830</creationdate><title>302. IMPACT OF ERAS BENCHMARK ACHIEVEMENTS AND HYBRID ROBOTIC ASSISTED ESOPHAGECTOMY ON RECOVERY AND READMISSION IN AN ERAS CENTER OVER TIME</title><author>Stiles, Erik ; Harrison, Madison ; Qaraqe, Taha ; Sternbach, Joel ; Low, Donald ; Hubka, Michal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1198-db3880ae096bcbb280cbf96c9e699505de2809cd29ce3270593f5992914853bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stiles, Erik</creatorcontrib><creatorcontrib>Harrison, Madison</creatorcontrib><creatorcontrib>Qaraqe, Taha</creatorcontrib><creatorcontrib>Sternbach, Joel</creatorcontrib><creatorcontrib>Low, Donald</creatorcontrib><creatorcontrib>Hubka, Michal</creatorcontrib><collection>CrossRef</collection><jtitle>Diseases of the esophagus</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stiles, Erik</au><au>Harrison, Madison</au><au>Qaraqe, Taha</au><au>Sternbach, Joel</au><au>Low, Donald</au><au>Hubka, Michal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>302. IMPACT OF ERAS BENCHMARK ACHIEVEMENTS AND HYBRID ROBOTIC ASSISTED ESOPHAGECTOMY ON RECOVERY AND READMISSION IN AN ERAS CENTER OVER TIME</atitle><jtitle>Diseases of the esophagus</jtitle><date>2023-08-30</date><risdate>2023</risdate><volume>36</volume><issue>Supplement_2</issue><issn>1120-8694</issn><eissn>1442-2050</eissn><abstract>Abstract Background Early recovery after surgery (ERAS) guidelines have provided an effective recovery approach for esophagectomy. Adherence to ERAS benchmarks leads to improvements in accelerated recovery over time. We evaluated differences in ERAS clinical benchmark achievements in patients undergoing hybrid robotic assisted esophagectomy (hRAMIE) and the impact on length of hospital stay (LOS). We also examined the overall performance of our ERAS program and impact of operative technique on recovery and readmissions over time. Methods A single-center prospective database of esophageal cancer patients was retrospectively analyzed between January 2020 and December 2022. All consecutive patients underwent hRAMIE within a standardized ERAS pathway. Impact of individual ERAS benchmark achievements on postoperative outcomes were evaluated according to LOS groups: accelerated (≤6 days, AR), targeted (7–8 days, TR), and delayed recovery (≥9 days, DR). Ability to achieve AR and readmission rates were compared with previous esophagectomy patient cohorts and institutional published data. Data were tested for normality with Shapiro–Wilk testing. Continuous variables were compared via ANOVA or Kruskal-Wallis testing. Categorical variables were compared via Fisher testing. Results Sixty-four patients underwent hRAMIE with a median LOS 5.5 days. AR, TR, and DR was achieved by 75.0%, 18.8%, and 6.3% patients, respectively. AR outperformed the other groups in ICU stay (p = 0.0046), transition to PO medications (p &lt; 0.0001), and chest tube removal (p = 0.0002). Complications (48.4%) were more frequent among the TR and DR groups (p = 0.0051). 30-day readmission rate of 9.4% did not differ among the recovery groups (AR 6.2%, TR 25.0%, DR 0%, p = 0.114). 90-day mortality was 4.7% and disproportionately impacted the DR group (p = 0.0203). AR increased overtime without impacting readmission rate compared to previous cohorts in our ERAS center (Figure 1). Conclusion Within a common ERAS pathway at a single center, adherence to recovery benchmarks in patients undergoing hRAMIE multiplies the impact of ERAS and evolving operative technique on accelerated recovery across time. Improvements in AR can be achieved without affecting readmission rates. Routine audit of achievements of ERAS benchmarks is necessary to maintain post-esophagectomy outcomes in a time of changing health care resources.</abstract><pub>Oxford University Press</pub><doi>10.1093/dote/doad052.128</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1120-8694
ispartof Diseases of the esophagus, 2023-08, Vol.36 (Supplement_2)
issn 1120-8694
1442-2050
language eng
recordid cdi_crossref_primary_10_1093_dote_doad052_128
source Oxford Journals Online
title 302. IMPACT OF ERAS BENCHMARK ACHIEVEMENTS AND HYBRID ROBOTIC ASSISTED ESOPHAGECTOMY ON RECOVERY AND READMISSION IN AN ERAS CENTER OVER TIME
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T00%3A05%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=302.%20IMPACT%20OF%20ERAS%20BENCHMARK%20ACHIEVEMENTS%20AND%20HYBRID%20ROBOTIC%20ASSISTED%20ESOPHAGECTOMY%20ON%20RECOVERY%20AND%20READMISSION%20IN%20AN%20ERAS%20CENTER%20OVER%20TIME&rft.jtitle=Diseases%20of%20the%20esophagus&rft.au=Stiles,%20Erik&rft.date=2023-08-30&rft.volume=36&rft.issue=Supplement_2&rft.issn=1120-8694&rft.eissn=1442-2050&rft_id=info:doi/10.1093/dote/doad052.128&rft_dat=%3Coup_cross%3E10.1093/dote/doad052.128%3C/oup_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1198-db3880ae096bcbb280cbf96c9e699505de2809cd29ce3270593f5992914853bc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/dote/doad052.128&rfr_iscdi=true